NOX 3.08% 6.7¢ noxopharm limited

Radiotherapy Improvements ALLOWED

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    Radiotherapy Improvements - Patent application US20190262451 - received Notice of Allowance from the USPTO on 16 September 2021.

    See: US20190262451 RADIOTHERAPY IMPROVEMENTS (wipo.int)

    This application had been the subject of a phone interview with the Examiner in April 2021, in which the Examiner seemed to suggest that the application would be allowable if an amended application noted that Abscopal Responses were by their very nature unpredictable.

    When this change was made, the Examiner surprisingly then objected to the British spelling of "tumour"! But the Examiner also noted that Claim 41 - the key claim of the entire application - was not rejected. Claim 41 sets out in detail the method of inducing an abscopal response.

    Noxopharm resubmitted the application, this time revolving around Claim 41, and Notice of Allowance has followed.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.7¢
Change
0.002(3.08%)
Mkt cap ! $19.58M
Open High Low Value Volume
6.5¢ 6.7¢ 6.5¢ $2.465K 37.67K

Buyers (Bids)

No. Vol. Price($)
2 32000 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 88899 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
6.5¢
  Change
0.002 ( 2.36 %)
Open High Low Volume
6.5¢ 6.5¢ 6.2¢ 21992
Last updated 15.32pm 29/03/2024 ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.